omega-n-methylarginine has been researched along with Diabetic Angiopathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cleland, SJ; Dawson, J; Harrow, C; Lees, KR; Quinn, T; Walters, MR; Weir, CJ | 1 |
| Alem, M; Cleland, S; Nazir, F; Small, M; Walters, M | 1 |
| Maxwell, SR; McKnight, JA; Waring, WS; Webb, DJ | 1 |
| Chang, K; Corbett, JA; Currie, MG; Hasan, KS; McDaniel, ML; Misko, TP; Moore, WM; Petrash, JM; Smith, SR; Tilton, RG | 1 |
| Colreavy, F; Green, D; Maiorana, A; O'Driscoll, G; Stanton, K; Taylor, R | 1 |
| Chang, K; Corbett, JA; Hasan, KS; Ido, Y; Lancaster, JR; McDaniel, ML; Sweetland, MA; Tilton, RG; Wang, JL; Williamson, JR | 1 |
4 trial(s) available for omega-n-methylarginine and Diabetic Angiopathies
| Article | Year |
|---|---|
Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes: a randomized trial.
Topics: Allopurinol; Carotid Arteries; Cerebrovascular Circulation; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Humans; Infusions, Intravenous; Male; Nitric Oxide; omega-N-Methylarginine; Placebos; Stroke | 2009 |
Inhibition of nitric oxide increases arterial stiffness in Type 2 diabetic patients.
Topics: Arterial Occlusive Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Enzyme Inhibitors; Humans; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine | 2007 |
Lowering serum urate does not improve endothelial function in patients with type 2 diabetes.
Topics: Acetylcholine; Adult; Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Placebos; Urate Oxidase; Uric Acid | 2007 |
Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus.
Topics: Acetylcholine; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enalapril; Endothelium, Vascular; Forearm; Humans; Middle Aged; Nitroprusside; omega-N-Methylarginine | 1999 |
2 other study(ies) available for omega-n-methylarginine and Diabetic Angiopathies
| Article | Year |
|---|---|
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
Topics: Aldehyde Reductase; Amino Acid Oxidoreductases; Animals; Arginine; Benzothiazoles; Blood Pressure; Body Weight; Capillary Permeability; Citrulline; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Imidazoles; Imidazolidines; Inositol; Iodine Radioisotopes; Male; Methylguanidine; Naphthalenes; Nitric Oxide Synthase; omega-N-Methylarginine; Phthalazines; Rats; Rats, Sprague-Dawley; Retina; Sciatic Nerve; Serum Albumin, Bovine; Sorbitol; Thiazoles; Uvea | 1993 |
Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Blood Vessels; Cells, Cultured; Diabetic Angiopathies; Enzyme Activation; Glucose; Guanidines; Insulin; Interleukin-1; Islets of Langerhans; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Regional Blood Flow | 1992 |